Does the Troponin I release pattern predict cardiac events in cancer patients undergoing high-dose chemotherapy?
Cancer patients undergoing high-dose chemotherapy
Assessment of Troponin I (TnI) release pattern after high-dose chemotherapy
Cardiac events in the 3 years thereafterhard clinical
Troponin I release patterns after high-dose chemotherapy can identify patients at varying risks for cardiac events over 3 years, guiding tailored monitoring and preventive care.
TnI release pattern after high-dose chemotherapy identifies patients at different risks of cardiac events in the 3 years thereafter. This stratification allows us to differentiate the monitoring program and to plan, in selected patients, preventive strategies aimed at improving clinical outcome.
Building similarity graph...
Analyzing shared references across papers
Loading...
Cardinale et al. (Tue,) studied this question.
synapsesocial.com/papers/69e6b9833ca116d60ece4c01 — DOI: https://doi.org/10.1161/01.cir.0000130926.51766.cc
Daniela Cardinale
University of Modena and Reggio Emilia
Maria Teresa Sandri
Cardio-Oncology
Alessandro Colombo
NTT (Italy)
Circulation
European Institute of Oncology
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: